Interferon (IFN), a key component of the body’s antiviral response, plays a central role in orchestrating the immune system's efforts to fight viral infections. Human papillomavirus (HPV) interferes with IFN production and its downstream effects, contributing to immune evasion and viral persistence. This chapter will address both the key innate immune mechanisms involved in controlling HPV infection and the viral strategies that promote HPV persistence and disease progression. Pattern recognition receptors (PRRs), type I-III IFNs, and IFN-stimulated genes (ISGs) expression changes in papillomavirus cell and animal infection models are reviewed. The controversial role of IFN therapy in HPV, which is the subject of ongoing debate and research, is also discussed. A better understanding of the complex relationship between IFN and HPV infection may contribute to potential advances in the treatment of HPV-associated diseases.

Interferons in human papillomavirus infection: antiviral effectors or immunopathogenic role? / Fracella, Matteo; Bugani, Ginevra; Maddaloni, Luca; Frasca, Federica; D'Auria, Alessandra; Santinelli, Letizia; Pierangeli, Alessandra; D'Ettorre, Gabriella; Scagnolari, Carolina. - (2025), pp. 193-216. [10.1016/b978-0-443-23932-8.00011-x].

Interferons in human papillomavirus infection: antiviral effectors or immunopathogenic role?

Fracella, Matteo;Bugani, Ginevra;Maddaloni, Luca;Frasca, Federica;D'Auria, Alessandra;Santinelli, Letizia;Pierangeli, Alessandra;d'Ettorre, Gabriella;Scagnolari, Carolina
2025

Abstract

Interferon (IFN), a key component of the body’s antiviral response, plays a central role in orchestrating the immune system's efforts to fight viral infections. Human papillomavirus (HPV) interferes with IFN production and its downstream effects, contributing to immune evasion and viral persistence. This chapter will address both the key innate immune mechanisms involved in controlling HPV infection and the viral strategies that promote HPV persistence and disease progression. Pattern recognition receptors (PRRs), type I-III IFNs, and IFN-stimulated genes (ISGs) expression changes in papillomavirus cell and animal infection models are reviewed. The controversial role of IFN therapy in HPV, which is the subject of ongoing debate and research, is also discussed. A better understanding of the complex relationship between IFN and HPV infection may contribute to potential advances in the treatment of HPV-associated diseases.
2025
Drug discovery stories - from bench to bedside
9780443239328
interferon; human papillomavirus; innate immunity
02 Pubblicazione su volume::02a Capitolo o Articolo
Interferons in human papillomavirus infection: antiviral effectors or immunopathogenic role? / Fracella, Matteo; Bugani, Ginevra; Maddaloni, Luca; Frasca, Federica; D'Auria, Alessandra; Santinelli, Letizia; Pierangeli, Alessandra; D'Ettorre, Gabriella; Scagnolari, Carolina. - (2025), pp. 193-216. [10.1016/b978-0-443-23932-8.00011-x].
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1754674
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact